PI-LAB-2025-043

Tirzepatide/Cagrilintide Blend, Independent Lab Report

Tirzepatide/Cagrilintide Blend 10mg · BioRegen Research

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 94.6% met the stated ≥95% claim. Content measured 100.9% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
94.6%

Label claimed ≥95%

Content accuracy
100.9%

10.09mg measured against 10mg claimed

Test recency
Older result

Published 16 months ago

Specimen PI-LAB-2025-043 Tested by Axiom Mass Spec Services 17 samples tested from this company Purity & Testing score 99/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 95% 94.6% Within analytical tolerance
Identity (MS) Tirzepatide/Cagrilintide Blend Confirmed Matches label
Content 10 mg 10.09 mg Within 5% of label

Methodology & chain of custody

HPLC-UV purity, ESI-MS identity, and Karl Fischer water content.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
R2736-25
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2025-043-report.pdf (document delivery arrives with the production storage backend)

More Tests, BioRegen Research

Tirzepatide (Compounded)
Purity 99.0% Verified
TB-500
Purity 99.2% Verified
CJC-1295
Purity 98.6% Verified

More Tests, Tirzepatide/Cagrilintide Blend

Tirzepatide/Cagrilintide Blend NextGen Peptides
Purity 97.6% Verified